Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
398 USD | +0.06% | +0.80% | -2.32% |
Apr. 25 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $497 From $515 | MT |
Apr. 23 | Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.32% | 103B | |
+0.40% | 95.71B | |
+2.36% | 22.02B | |
-16.75% | 20.9B | |
-9.07% | 17.85B | |
-42.83% | 16.21B | |
-15.16% | 15.52B | |
+3.64% | 13.86B | |
+34.69% | 12.04B | |
-25.83% | 8.08B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-30-2022 09